AA
ABMD

Altman Advisors’s Abiomed Inc ABMD Stock Holding History

Altman Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,652
Closed -$794K – 92
2019
Q4 		$794K Buy
4,652
+2,547
+121% +$472K 0.63% 55
2019
Q3 		$374K Sell
2,105
-2,025
-49% -$438K 0.32% 60
2019
Q2 		$1.08M Buy
4,130
+1,246
+43% +$331K 0.9% 53
2019
Q1 		$824K Buy
2,884
+2,095
+266% +$696K 0.76% 53
2018
Q4 		$256K Hold
789
– – 0.28% 58
2018
Q3 		$355K Sell
789
-29,232
-97% -$11.5M 0.32% 55
2018
Q2 		$2.78K Buy
+30,021
New +$10.9M 2.55% 6

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Altman Advisors's ABMD Position: Q1 2020 in Review

Altman Advisors sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 4,652 shares — an estimated $794K sold.

Altman Advisors first reported a position in ABMD in Q2 2018 and held it in 7 quarters. The position peaked at $1.08M in Q2 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Altman Advisors reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Altman Advisors sold 4,652 Abiomed Inc shares in Q1 2020, an estimated $794K.
  • Altman Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 7 quarters.
  • Altman Advisors's Abiomed Inc position peaked at $1.08M in Q2 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Altman Advisors's 13F filing for Q1 2020, filed 20 Apr 2020.